Skip to content

Clinical trials

Terminated Phase 1/2 Myelodysplastic Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 1/2 Status: Terminated Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20074
20084
20091
20101
20111
20121
20133
20142
20153
20163
20176
20183
20191
20202
20217
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated49

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center10
Incyte Corporation5
Bellicum Pharmaceuticals3
GlaxoSmithKline2
Masonic Cancer Center, University of Minnesota2
National Cancer Institute (NCI)2
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2
Washington University School of Medicine2
Astex Pharmaceuticals, Inc.1
Biosuccess Biotech Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes49
Leukemia, Myeloid, Acute28
Leukemia19
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
Lymphoma9
Leukemia, Myelomonocytic, Chronic8
Multiple Myeloma8
Hematologic Neoplasms7
Lymphoma, Non-Hodgkin7
Primary Myelofibrosis6

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.